JAZZ logo

Jazz Pharmaceuticals (JAZZ) Selling, general & administrative expenses

annual SGA:

$1.39B+$42.19M(+3.14%)
December 31, 2024

Summary

  • As of today (May 21, 2025), JAZZ annual SGA is $1.39 billion, with the most recent change of +$42.19 million (+3.14%) on December 31, 2024.
  • During the last 3 years, JAZZ annual SGA has fallen by -$66.39 million (-4.57%).
  • JAZZ annual SGA is now -4.57% below its all-time high of $1.45 billion, reached on December 31, 2021.

Performance

JAZZ SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

quarterly SGA:

$514.01M+$144.73M(+39.19%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ quarterly SGA is $514.01 million, with the most recent change of +$144.73 million (+39.19%) on March 1, 2025.
  • Over the past year, JAZZ quarterly SGA has increased by +$162.30 million (+46.15%).
  • JAZZ quarterly SGA is now at all-time high.

Performance

JAZZ quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

TTM SGA:

$3.97B+$170.77M(+4.50%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ TTM SGA is $3.97 billion, with the most recent change of +$170.77 million (+4.50%) on March 1, 2025.
  • Over the past year, JAZZ TTM SGA has increased by +$2.57 billion (+184.17%).
  • JAZZ TTM SGA is now -9.51% below its all-time high of $4.39 billion.

Performance

JAZZ TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

JAZZ Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.1%+46.1%+184.2%
3 y3 years-4.6%+66.5%+164.6%
5 y5 years+88.0%+146.7%+410.6%

JAZZ Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-4.6%+3.1%at high+72.5%at high+22.8%
5 y5-year-4.6%+88.0%at high+168.6%-9.5%+22.8%
alltimeall time-4.6%+5782.1%at high+3663.7%-9.5%+294.0%

JAZZ Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$514.01M(+39.2%)
$1.55B(+11.7%)
Dec 2024
$1.39B(+3.1%)
$369.29M(+13.4%)
$1.39B(-1.9%)
Sep 2024
-
$325.77M(-3.8%)
$1.41B(+1.3%)
Jun 2024
-
$338.52M(-3.7%)
$1.39B(-0.2%)
Mar 2024
-
$351.71M(-11.2%)
$1.40B(+4.0%)
Dec 2023
$1.34B(-5.2%)
$396.03M(+28.5%)
$1.34B(+1.0%)
Sep 2023
-
$308.31M(-9.5%)
$1.33B(-3.6%)
Jun 2023
-
$340.84M(+14.4%)
$1.38B(-1.8%)
Mar 2023
-
$297.92M(-22.3%)
$1.41B(-0.8%)
Dec 2022
$1.42B(-2.4%)
$383.20M(+6.9%)
$1.42B(-1.1%)
Sep 2022
-
$358.48M(-2.2%)
$1.43B(-0.4%)
Jun 2022
-
$366.47M(+18.7%)
$1.44B(-4.2%)
Mar 2022
-
$308.81M(-22.5%)
$1.50B(+3.3%)
Dec 2021
$1.45B(+69.9%)
$398.46M(+9.6%)
$1.45B(+11.6%)
Sep 2021
-
$363.68M(-15.2%)
$1.30B(+13.7%)
Jun 2021
-
$429.03M(+64.7%)
$1.14B(+26.2%)
Mar 2021
-
$260.51M(+5.4%)
$906.34M(+6.1%)
Dec 2020
$854.23M(+15.9%)
$247.17M(+19.3%)
$854.23M(+4.0%)
Sep 2020
-
$207.25M(+8.3%)
$821.34M(+3.6%)
Jun 2020
-
$191.41M(-8.2%)
$792.79M(+2.0%)
Mar 2020
-
$208.40M(-2.7%)
$777.39M(+5.5%)
Dec 2019
$736.94M(+7.8%)
$214.28M(+19.9%)
$736.94M(+7.7%)
Sep 2019
-
$178.71M(+1.5%)
$684.53M(+3.5%)
Jun 2019
-
$176.01M(+4.8%)
$661.70M(+2.7%)
Mar 2019
-
$167.95M(+3.8%)
$644.26M(-5.7%)
Dec 2018
$683.53M(+25.6%)
$161.87M(+3.8%)
$683.53M(+2.8%)
Sep 2018
-
$155.87M(-1.7%)
$664.72M(+4.9%)
Jun 2018
-
$158.58M(-23.5%)
$633.37M(+4.3%)
Mar 2018
-
$207.21M(+44.9%)
$607.11M(+11.6%)
Dec 2017
$544.16M(+8.2%)
$143.05M(+14.9%)
$544.16M(+3.0%)
Sep 2017
-
$124.52M(-5.9%)
$528.25M(+0.0%)
Jun 2017
-
$132.33M(-8.3%)
$528.09M(+1.9%)
Mar 2017
-
$144.25M(+13.5%)
$518.38M(+3.1%)
Dec 2016
$502.89M(+12.0%)
$127.14M(+2.2%)
$502.89M(+0.3%)
Sep 2016
-
$124.37M(+1.4%)
$501.31M(+4.2%)
Jun 2016
-
$122.62M(-4.8%)
$480.98M(+3.3%)
Mar 2016
-
$128.76M(+2.6%)
$465.50M(+3.6%)
DateAnnualQuarterlyTTM
Dec 2015
$449.12M(+10.6%)
$125.56M(+20.7%)
$449.12M(+4.6%)
Sep 2015
-
$104.04M(-2.9%)
$429.26M(+2.5%)
Jun 2015
-
$107.13M(-4.7%)
$418.71M(+1.6%)
Mar 2015
-
$112.39M(+6.3%)
$412.14M(+1.5%)
Dec 2014
$406.11M(+33.5%)
$105.69M(+13.0%)
$406.11M(+6.4%)
Sep 2014
-
$93.50M(-7.0%)
$381.72M(+5.1%)
Jun 2014
-
$100.56M(-5.5%)
$363.19M(+6.8%)
Mar 2014
-
$106.36M(+30.8%)
$340.14M(+11.8%)
Dec 2013
$304.30M(+35.9%)
$81.30M(+8.4%)
$304.30M(+7.0%)
Sep 2013
-
$74.97M(-3.3%)
$284.38M(+5.2%)
Jun 2013
-
$77.51M(+9.9%)
$270.33M(+8.1%)
Mar 2013
-
$70.53M(+14.9%)
$250.05M(+11.7%)
Dec 2012
$223.88M(+105.5%)
$61.38M(+0.7%)
$223.88M(+12.6%)
Sep 2012
-
$60.92M(+6.5%)
$198.89M(+18.0%)
Jun 2012
-
$57.22M(+29.0%)
$168.51M(+26.3%)
Mar 2012
-
$44.36M(+21.9%)
$133.38M(+22.4%)
Dec 2011
$108.94M(+57.9%)
$36.38M(+19.1%)
$108.94M(+21.6%)
Sep 2011
-
$30.55M(+38.3%)
$89.62M(+16.2%)
Jun 2011
-
$22.09M(+11.0%)
$77.11M(+6.9%)
Mar 2011
-
$19.91M(+16.6%)
$72.12M(+4.5%)
Dec 2010
$69.00M(+17.6%)
$17.07M(-5.4%)
$69.00M(+2.0%)
Sep 2010
-
$18.04M(+5.5%)
$67.64M(+4.6%)
Jun 2010
-
$17.10M(+1.8%)
$64.67M(+5.6%)
Mar 2010
-
$16.79M(+6.8%)
$61.23M(+4.4%)
Dec 2009
$58.65M(-47.4%)
$15.72M(+4.4%)
$58.65M(-7.1%)
Sep 2009
-
$15.06M(+10.3%)
$63.12M(-12.8%)
Jun 2009
-
$13.66M(-3.9%)
$72.39M(-22.0%)
Mar 2009
-
$14.22M(-29.6%)
$92.84M(-16.7%)
Dec 2008
$111.40M(+41.8%)
$20.18M(-17.0%)
$111.40M(-6.5%)
Sep 2008
-
$24.33M(-28.7%)
$119.17M(+5.5%)
Jun 2008
-
$34.11M(+4.1%)
$112.92M(-1.3%)
Mar 2008
-
$32.78M(+17.3%)
$114.45M(+19.2%)
Dec 2007
$78.54M(+52.8%)
$27.96M(+54.7%)
$96.01M(+41.1%)
Sep 2007
-
$18.07M(-49.3%)
$68.05M(+36.2%)
Jun 2007
-
$35.64M(+148.6%)
$49.98M(+248.6%)
Mar 2007
-
$14.34M
$14.34M
Dec 2006
$51.38M(+118.2%)
-
-
Dec 2005
$23.55M
-
-

FAQ

  • What is Jazz Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual SGA year-on-year change?
  • What is Jazz Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly SGA year-on-year change?
  • What is Jazz Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals TTM SGA year-on-year change?

What is Jazz Pharmaceuticals annual SGA?

The current annual SGA of JAZZ is $1.39B

What is the all time high annual SGA for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual SGA is $1.45B

What is Jazz Pharmaceuticals annual SGA year-on-year change?

Over the past year, JAZZ annual SGA has changed by +$42.19M (+3.14%)

What is Jazz Pharmaceuticals quarterly SGA?

The current quarterly SGA of JAZZ is $514.01M

What is the all time high quarterly SGA for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly SGA is $514.01M

What is Jazz Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, JAZZ quarterly SGA has changed by +$162.30M (+46.15%)

What is Jazz Pharmaceuticals TTM SGA?

The current TTM SGA of JAZZ is $3.97B

What is the all time high TTM SGA for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high TTM SGA is $4.39B

What is Jazz Pharmaceuticals TTM SGA year-on-year change?

Over the past year, JAZZ TTM SGA has changed by +$2.57B (+184.17%)
On this page